![]() Urovant Sciences Urovant Sciences is a biopharmaceutical company focused on developing novel therapies for urologic conditions. | ![]() Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. | ![]() Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. | |
Founding Date | Founding Date 2016 | Founding Date 1996 | Founding Date 1781 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Irvine, US HQ Basel, CH | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | |
Employees | Employees 3950% increase | Employees 75,883 | Employees 47,4554% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) ¥4.6t (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $8.4b (FY, 2025) | Cost of goods ¥818.8b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $49.8b (FY, 2025) | Gross profit ¥3.8t (FY, 2025) |
Net income | Net income ($146.7m) (FY, 2020) | Net income $14b (FY, 2025) | Net income ¥108.1b (FY, 2025) |
Operating ⚠ | |||
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products 44 (FY, 2022) | Phase III Trials Products 17 (May, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 6.5m | Total funding raised $ 57.8m |

Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View company
Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
View company